600
Participants
Start Date
July 30, 2020
Primary Completion Date
April 4, 2021
Study Completion Date
July 5, 2021
intermediate dose Enoxaparin/ unfractionated heparin
Intermediate dose anticoagulation according to creatinine clearance and weight
standard prophylactic dose Enoxaparin/ unfractionated heparin
Standard prophylaxis anticoagulation according to creatinine clearance and weight
Atorvastatin 20mg
Statin
Matched placebo
Matched placebo to atorvastatin 20 mg
Masih Daneshvari Hospital, Tehran
Brigham and Women's Hospital
OTHER
Tehran Heart Center
OTHER
Masih Daneshvari Hospital
OTHER
Hazrat Rasool Hospital
OTHER
Modarres Hospital
OTHER
Firuzgar hospital affiliated to Iran University of Medical Sciences
OTHER
Imam Khomeini Hospital
OTHER
Sina Hospital, Iran
OTHER
Tabriz University of Medical Sciences
OTHER
Shariati Hospital
OTHER
Imam Ali Hospital
UNKNOWN
Labbafinejhad Hospital
OTHER
Rajaie Cardiovascular Medical and Research Center
OTHER